Literature DB >> 16166617

Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia.

Sachin Yende1, Elaine I Tuomanen, Richard Wunderink, Alka Kanaya, Anne B Newman, Tamara Harris, Nathalie de Rekeneire, Stephen B Kritchevsky.   

Abstract

RATIONALE: Elevated proinflammatory cytokines are associated with severity of pneumonia, but the role of preinfection cytokine levels in the predisposition to pneumonia in humans is less clear.
OBJECTIVE: To ascertain role of preinfection inflammatory markers on susceptibility to community-acquired pneumonia (CAP).
METHODS: Longitudinal analysis over 6.5 yr of a cohort that consisted of 70- to 79-yr-old well-functioning elderly individuals. MEASUREMENTS: Association between preinfection tumor necrosis factor (TNF), interleukin 6 (IL-6), and C-reactive protein (CRP) levels and CAP requiring hospitalization.
RESULTS: Of the 3,075 participants, 161 (5.2%) developed at least one episode of CAP requiring hospitalization over a median duration of 3.3 yr. The highest tertiles of TNF (> 3.7 pg/ml) and IL-6 (> 2.4 pg/ml) were associated with increased risk of CAP, and the adjusted odds ratios were 1.6 (95% confidence interval [CI], 1.02-2.7) and 1.7 (95% CI, 1.1-2.8), respectively. The adjusted risk of CAP with at least one of these markers in the highest tertile was 1.6 (95% CI, 1.1-2.3). TNF and IL-6 levels in the highest tertile had a synergistic effect (p = 0.01 for interaction), and risk of CAP for both markers in the highest tertile was 2.8 (95% CI, 1.8-4.3). An FEV(1) of 50% or less of predicted was associated with the highest risk of CAP (adjusted odds ratio, 3.6; 95% CI, 2.3-5.6). Furthermore, TNF and IL-6 levels modified risk of CAP in participants with coexisting medical conditions and history of smoking.
CONCLUSION: In the well-functioning elderly subjects, preinfection systemic levels of TNF and IL-6 were associated with higher risk of CAP requiring hospitalization in smokers and those with coexisting medical conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16166617      PMCID: PMC2718438          DOI: 10.1164/rccm.200506-888OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  34 in total

1.  Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention.

Authors:  M S Niederman; L A Mandell; A Anzueto; J B Bass; W A Broughton; G D Campbell; N Dean; T File; M J Fine; P A Gross; F Martinez; T J Marrie; J F Plouffe; J Ramirez; G A Sarosi; A Torres; R Wilson; V L Yu
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

2.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.

Authors:  A Bhowmik; T A Seemungal; R J Sapsford; J A Wedzicha
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

3.  Systemic cytokine levels in community-acquired pneumonia and their association with disease severity.

Authors:  G Antunes; S A Evans; J L Lordan; A J Frew
Journal:  Eur Respir J       Date:  2002-10       Impact factor: 16.671

4.  Early response cytokines and innate immunity: essential roles for TNF receptor 1 and type I IL-1 receptor during Escherichia coli pneumonia in mice.

Authors:  J P Mizgerd; M R Spieker; C M Doerschuk
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

5.  Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure.

Authors:  M Petretta; G L Condorelli; L Spinelli; F Scopacasa; M de Caterina; D Leosco; M L Vicario; D Bonaduce
Journal:  Am Heart J       Date:  2000-12       Impact factor: 4.749

6.  Roles of tumor necrosis factor receptor signaling during murine Escherichia coli pneumonia.

Authors:  J P Mizgerd; J J Peschon; C M Doerschuk
Journal:  Am J Respir Cell Mol Biol       Date:  2000-01       Impact factor: 6.914

7.  Airflow limitation is underrecognized in well-functioning older people.

Authors:  G W Waterer; J Y Wan; S B Kritchevsky; R G Wunderink; S Satterfield; D C Bauer; A B Newman; D R Taaffe; R L Jensen; R O Crapo
Journal:  J Am Geriatr Soc       Date:  2001-08       Impact factor: 5.562

8.  Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2 years in young women.

Authors:  Gloria Y F Ho; Xiao-Nan Xue; Robert D Burk; Robert C Kaplan; Elaine Cornell; Mary Cushman
Journal:  Cytokine       Date:  2005-04-07       Impact factor: 3.861

9.  A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women.

Authors:  I Baik; G C Curhan; E B Rimm; A Bendich; W C Willett; W W Fawzi
Journal:  Arch Intern Med       Date:  2000-11-13

10.  Modulation of bacterial growth by tumor necrosis factor-alpha in vitro and in vivo.

Authors:  Jin-Hwa Lee; Lorenzo Del Sorbo; Aye Aye Khine; Joyce de Azavedo; Donald E Low; David Bell; Stefan Uhlig; Arthur S Slutsky; Haibo Zhang
Journal:  Am J Respir Crit Care Med       Date:  2003-09-04       Impact factor: 21.405

View more
  61 in total

1.  Effects of Aging on Inflammation and Hemostasis through the Continuum of Critical Illness.

Authors:  Sachin S Kale; Sachin Yende
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

Review 2.  Pneumococci: immunology of the innate host response.

Authors:  Gavin K Paterson; Carlos J Orihuela
Journal:  Respirology       Date:  2010-07-20       Impact factor: 6.424

3.  Is Pneumonia a Risk Factor or a Risk Marker for Long-Term Mortality?

Authors:  Carlos G Grijalva
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

Review 4.  Inflammation and Pneumonia: Why Are Some More Susceptible than Others?

Authors:  Joseph P Mizgerd
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

5.  Dysregulated inflammation as a risk factor for pneumonia in the elderly.

Authors:  Angela R Boyd; Carlos J Orihuela
Journal:  Aging Dis       Date:  2011-12       Impact factor: 6.745

6.  Epidemiology and long-term clinical and biologic risk factors for pneumonia in community-dwelling older Americans: analysis of three cohorts.

Authors:  Sachin Yende; Karina Alvarez; Laura Loehr; Aaron R Folsom; Anne B Newman; Lisa A Weissfeld; Richard G Wunderink; Stephen B Kritchevsky; Kenneth J Mukamal; Stephanie J London; Tamara B Harris; Doug C Bauer; Derek C Angus
Journal:  Chest       Date:  2013-09       Impact factor: 9.410

7.  Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis.

Authors:  Sachin Yende; Gina D'Angelo; John A Kellum; Lisa Weissfeld; Jonathan Fine; Robert D Welch; Lan Kong; Melinda Carter; Derek C Angus
Journal:  Am J Respir Crit Care Med       Date:  2008-03-27       Impact factor: 21.405

Review 8.  The evolution of an inflammatory response.

Authors:  Stephen F Lowry
Journal:  Surg Infect (Larchmt)       Date:  2009-10       Impact factor: 2.150

9.  4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia.

Authors:  Sachin Yende; Derek C Angus; Jingzhong Ding; Anne B Newman; John A Kellum; Rongling Li; Robert E Ferrell; Joseph Zmuda; Stephen B Kritchevsky; Tamara B Harris; Melissa Garcia; Kristine Yaffe; Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

Review 10.  The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy.

Authors:  Jean-Paul Mira; Adeline Max; Pierre-Regis Burgel
Journal:  Crit Care       Date:  2008-11-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.